Fig. 3
From: A meta-analysis of BRF2 as a prognostic biomarker in invasive breast carcinoma
BRF2 DNA copy number is increased in ductal breast carcinoma. a BRF2 DNA copy frequency by general cancer type. b BRF2 DNA copy frequency by breast cancer sub-type. Red shading denotes increased BRF2 copy number. c Scatterplot representing individual patient BRF2 copy number value on x-axis. The data sets analyzed during the current study are available at https://powertools.oncomine.com/. Queries of Oncomine Power Tools were performed in September 2019, October 2019, November 2019, January 2020, February 2020, and March 2020